Charitable Projects
In addition to his commitment to public service, Eric Gertler has devoted considerable time to various charitable projects and endeavors. Through his leadership at the Zuckerman Family Office, Eric has focused on projects within Israel, programs to support leadership, advances in basic scientific research, and projects that contribute to civic engagement, particularly in New York City. Here are just a few of the initiatives he supports:
Zuckerman STEM Scholar Program
This program was established in 2015 to achieve the philanthropic vision of Mortimer B. Zuckerman to enhance the collaboration and communication among the most promising scholars in science, technology, engineering and math, in Israel, the United States and Canada. As of May 2025, the program had supported 290 scholars and had established 52 new STEM labs in Israel. Read about it in U.S. News & World Report, the Observer, and The Jerusalem Post.
In March 2025, the Zuckerman Israel Institute and Zuckerman Family Foundation announced a transformative gift to advance neuroscience in Israel. The cornerstone of the initiative includes a lead gift to establish the Zuckerman Center for Research on Learning, Memory, and Cognition at Weizmann Institute’s Azrieli Institute for Brain and Neural Sciences. An additional gift created the Zuckerman National Neuroscience Research Program to further promote collaboration in the neurosciences between leading academic institutions in Israel and the United States. Read more.
Western Wall Heritage Center
The Center serves as an educational center for individuals and groups coming to the Western Wall. Read more.
Zuckerman Harvard Fellowship
This fellowship equips outstanding young individuals from the fields of medicine, law and business to provide leadership for the common good by making it possible for them to pursue public service degrees at the Harvard Kennedy School. Read more.
Memorial Sloan Kettering
Support for various initiatives including groundbreaking research into more effective therapies for those impacted by glioblastoma. Read more.